Alzheimer’s drug trial brings pivotal test of maligned brain plaque theory
A late-stage trial of an Alzheimer’s drug set to generate results within weeks is shaping up as a pivotal moment in a three-decade quest to prove that removing sticky amyloid plaques from the brain can slow down the disease.
